Search results
Niemann-Pick disease type C: Rare disease patients awaiting disease-modifying drugs
Pharmaceutical Technology via Yahoo Finance· 19 hours agoIn the US, miglustat is not approved for NPC, and it is used off-label by doctors as the only...
Dockcase Studio Smart USB-C Hub 8-in-1 Review - Powerful hub with perplexing features. - General...
AppleInsider· 7 hours agoUSB-C Hub 8-in-1 is designed for creators and power users and packs a ton of features into its tiny,...
PNY Elite-X Type-C Drive review: specs, performance, cost
AppleInsider· 6 days agoThe PNY Elite-X Type C Drive is a cheap, quick, and extremely portable storage solution for anyone...
What Is Copilot? Microsoft's AI Assistant Explained
PC Magazine· 2 hours agoFor example, if you type in, “Summarize this memo in two sentences,” Copilot will do just that by giving you a concise written summary in the chat...
RAAF E-7A completes training with USAF Air Combat Command
FlightGlobal· 6 hours agoA Boeing E-7A Wedgetail airborne early warning & control (AEW&C) aircraft of the Royal Australian...
The ‘Non-Negotiable’ Shoes Podiatrists & TikTok Say You Need for Traveling Europe
STYLECASTER via Yahoo News· 12 hours agoDon’t forget about straps, too! Adjustable straps over the toes, behind the heel, or around the...
WD My Passport, Works with USB-C review: A fat 6TB for not a lot of cash
PC World· 23 hours agoThis inventively monikered external 2.5-inch hard drive is available with up to 6TB of capacity and...
Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead...
The Joplin Globe· 23 hours ago(Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology, reports positive
Citigroup Inc. (NYSE:C) is a favorite amongst institutional investors who own 71%
Simply Wall St. via Yahoo Finance· 5 days ago(NYSE:C), then you'll have to look at the makeup of its share registry. We can see that...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 6 days agoFood & Drug Administration (“FDA”) for the evaluation of a proposed clinical study of Bucillamine, an oral thiol-based drug with...